SCHEMBL722381

SCHEMBL722381

c1cncc(-c2ccnc3cc(-c4ccc(N5CCOCC5)cc4)oc23)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.47
CLK1 P49759 1/20 0.46
DYRK1A Q13627 1/20 0.46
PIK3CA P42336 2/20 0.45
PIK3CB P42338 1/20 0.45
PIK3CG P48736 1/20 0.45
RPS6KA3 P51812 2/20 0.45
RPS6KA2 Q15349 1/20 0.45
RPS6KA1 Q15418 1/20 0.45
LRRK2 Q5S007 1/20 0.44
JAK2 O60674 1/20 0.44
JAK3 P52333 1/20 0.44
PTK2 Q05397 1/20 0.44
PIK3R2 O00459 1/20 0.42
P4HTM Q9NXG6 1/20 0.42
CHEK1 O14757 1/20 0.42
MAPK10 P53779 1/20 0.42
ACVR1B P36896 2/20 0.42
TGFBR1 P36897 2/20 0.42
BMPR1B O00238 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL723929 0.89 PIM1 (0.50) RPS6KA3JAK2ACVR1BTGFBR1BMPR1B
SCHEMBL723388 0.89 KDM4E (0.51) PRKDCPIK3CAPIK3CBPIK3CGJAK2
SCHEMBL724754 0.89 CNR2 (0.47) PRKDCPIK3CAPIK3CBPIK3CGLRRK2
SCHEMBL723621 0.82 MAPK10 (0.51) LRRK2PIK3R2MAPK10ACVR1BTGFBR1
SCHEMBL724726 0.78 CNR2 (0.50) PIK3CBATR
SCHEMBL15209104 0.78 MAPKAPK2 (0.48) RPS6KA3CHEK1ACVR1BTGFBR1BMPR1B
SCHEMBL723758 0.78 DYRK1A (0.47) DYRK1APIK3CALRRK2CHEK1KDR
SCHEMBL722890 0.78 PRKDC (0.48) PRKDCMAPK10ACVR1BTGFBR1BMPR1B
SCHEMBL723599 0.76 PIK3CA (0.43) PIK3CA
SCHEMBL725108 0.76 KDR (0.54) JAK3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP claimed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US claimed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US claimed
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP claimed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO claimed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB PRKDC 180/4885CLK1 1153/4885DYRK1A 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.